The Photon UVC Vet Wins Technology Award at AHNTI EU Innovation Showcase
The Photon UVC Vet, designed by Smallfry for Photon Therapeutics, has won the Technology & Innovation Award at the AHNTI EU Innovation Showcase 2026 for its transformative treatment for corneal infections in animals.
The award was announced at the AHNTI (Animal Health, Nutrition & Technology Innovation) EU 2026 conference in London, where finalists pitched their technologies to an audience of more than 850 senior leaders from across the animal health sector, including investors, pharmaceutical and biotech companies, CDMOs, and strategic partners.
Mark Leddy, CEO of Photon Therapeutics, said:
“Being recognised with the Innovation & Technology Award at AHNTI EU is an incredible honour. The calibre of innovation presented at the showcase was outstanding, and it’s exciting to be part of an organisation working to redefine the future of animal health through science and technology.”
Smallfry’s Impact: Developing the Photon UVC Vet
Photon commissioned Smallfry to help commercialise its Photon UVC technology, which delivers a fast, effective and drug-free treatment for corneal infections with no pain and no contact.
With a focus on creating a cutting-edge and intuitive design, Smallfry transformed the benchtop technology into the compact, professional, and production-ready Photon UVC Vet device.
